Expert Review of Clinical Immunology
Comparative efficacy of systemic treatments for atopic dermatitis in adults
Volume 20, Issue 3, March 2024, Page 313-320.
Expert Review of Clinical Immunology
How should we approach management of childhood onset chronic anterior uveitis refractory to adalimumab?
Volume 20, Issue 3, March 2024, Page 267-276.
Expert Review of Clinical Immunology
Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population
Volume 20, Issue 2, February 2024, Page 237-244.
Expert Review of Clinical Immunology
At the cutting-edge: what’s the latest in imaging to diagnose Sjögren’s disease?
Volume 20, Issue 2, February 2024, Page 135-139.
Expert Review of Clinical Immunology
A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults
Volume 20, Issue 3, March 2024, Page 255-266.
Expert Review of Clinical Immunology
Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA)
Volume 20, Issue 2, February 2024, Page 141-153.
Expert Review of Clinical Immunology
A review of low dose interleukin-2 therapy in management of chronic graft-versus-host-disease
Volume 20, Issue 2, February 2024, Page 169-184.
Expert Review of Clinical Immunology
Bimekizumab for the treatment of psoriatic arthritis
Volume 20, Issue 2, February 2024, Page 155-168.